Shaun Rodriguez, Director of Life Science Research, joined Casdin Capital in 2015. His coverage universe is focused on life science tools, diagnostics, healthcare information technology and services, and industrial applications of biotechnology.
Prior to joining Casdin, Shaun served as Director and Senior Research Analyst at Cowen and Company in the firm’s healthcare equity research group where he was recognized as a 2014 Rising Stars of Wall Street by Institutional Investor. Previously, Shaun worked in early-stage healthcare venture capital as an Associate with the Partners Innovation Fund, and in strategic business development with Partners Healthcare.
Shaun earned a PhD in Biological Sciences from Harvard University. He also holds a B.S. from the University of Maine and an M.S. from Tufts University. He currently serves on the Board of Trustees of the Lawrence General Hospital, Massachusetts.
This person is not in any offices
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.